Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001243840 | SCV001417023 | pathogenic | Autoimmune lymphoproliferative syndrome type 2B | 2019-10-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val122Thrfs*31) in the CASP8 gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CASP8 are known to be pathogenic (PMID: 12353035, 25814141). This variant has not been reported in the literature in individuals with CASP8-related conditions. This variant is present in population databases (rs765672355, ExAC 0.005%). |